Abidi Syed, Nili Misha, Serna Stephania, Kim Simon, Hazlett Christopher, Edgell Heather
School of Kinesiology and Health Sciences, York University, Toronto, Ontario, Canada; and.
School of Kinesiology and Health Sciences, York University, Toronto, Ontario, Canada; and
J Appl Physiol (1985). 2017 Aug 1;123(2):375-386. doi: 10.1152/japplphysiol.00035.2017. Epub 2017 May 18.
Women experience orthostatic intolerance more than men, and they experience faintness more in the early follicular [i.e., low-hormone (LH)] than luteal [i.e., high-hormone (HH)] phase of the menstrual cycle. Men ( = 13, 25.8 ± 1.8 yr old) and women in the LH (; placebo) and HH (; high dose) phases of the menstrual cycle with (OC; = 14, 22.0 ± 0.8 yr old) or without (NOC; = 12, 21.8 ± 0.5 yr old) oral contraceptive (OC) use underwent the Valsalva maneuver and a supine-sit-stand protocol. Blood pressure, normalized stroke volume [stroke volume index (SVi)], cardiac output index, heart rate, end-tidal CO, and middle cerebral artery (MCA) blood flow velocity were measured. When subjected to the Valsalva maneuver, all women had a greater increase in diastolic and mean MCA blood flow velocity than men ( ≤ 0.065), with no significant effect of menstrual cycle phase or OC use. When subjected to the supine-sit-stand protocol, men had lower MCA blood flow velocity ( < 0.038) than all women, and SVi was higher in men than in the NOC group in all postures ( < 0.011) and in the OC group in the LH phase of the menstrual cycle during standing ( = 0.010). Only men experienced higher resistance index ( < 0.001) and pulsatility index ( < 0.001) with standing. The OC group had lower end-tidal CO ( = 0.002) than the NOC group ( = 0.030) and men ( ≤ 0.067). SVi ( = 0.004) and cardiac output index ( = 0.008) were higher in the OC than NOC group. A tendency toward a lower mean MCA blood flow velocity ( = 0.058) and higher SVi ( = 0.059) and pulsatility index ( = 0.058) was noted in the HH than LH phase. Mean arterial pressure was higher in the OC than NOC group in the LH phase ( = 0.049) and lower in the HH than LH phase ( = 0.014). Our results indicate that cycling estrogens/progestins can influence ventilatory, cardiovascular, and/or cerebrovascular physiology. We have found sex differences in the cerebrovascular response to the Valsalva maneuver and standing. Men have greater cerebral vasoconstriction (or women have greater cerebral vasodilation) during late phase II of the Valsalva maneuver, and the cerebrovascular resistance index increases in men, but not in women, during standing. Furthermore, our findings indicate that both the menstrual cycle phase and oral contraceptive use can influence cardiovascular function both at rest and during active standing.
女性比男性更容易出现体位性不耐受,且在月经周期的卵泡早期[即激素水平低(促黄体生成素)]比黄体期[即激素水平高(高激素)]更容易感到头晕。处于月经周期促黄体生成素(;安慰剂)和高激素(;高剂量)阶段、正在服用(口服避孕药组; = 14,22.0 ± 0.8岁)或未服用(非口服避孕药组; = 12,21.8 ± 0.5岁)口服避孕药的男性( = 13,25.8 ± 1.8岁)和女性接受了瓦尔萨尔瓦动作及仰卧 - 坐立 - 站立方案。测量了血压、标准化每搏输出量[每搏输出量指数(SVi)]、心输出量指数、心率、呼气末二氧化碳分压和大脑中动脉(MCA)血流速度。在进行瓦尔萨尔瓦动作时,所有女性舒张期和平均MCA血流速度的增加幅度均大于男性(≤ 0.065),月经周期阶段或口服避孕药的使用对此无显著影响。在进行仰卧 - 坐立 - 站立方案时,男性的MCA血流速度低于所有女性(< 0.038),且在所有姿势下男性的SVi均高于非口服避孕药组(< 0.011),在月经周期促黄体生成素阶段站立时,口服避孕药组的SVi也高于该组( = 0.010)。只有男性站立时阻力指数(< 0.001)和搏动指数(< 0.001)更高。口服避孕药组的呼气末二氧化碳分压低于非口服避孕药组( = 0.030)和男性(≤ 0.067)( = 0.002)。口服避孕药组的SVi( = 0.004)和心输出量指数( = 0.008)高于非口服避孕药组。与促黄体生成素阶段相比,高激素阶段MCA平均血流速度有降低趋势( = 0.058),SVi( = 0.059)和搏动指数( = 0.058)有升高趋势。在促黄体生成素阶段,口服避孕药组的平均动脉压高于非口服避孕药组( = 0.049),在高激素阶段低于促黄体生成素阶段( = 0.014)。我们的研究结果表明,周期性的雌激素/孕激素可影响通气、心血管和/或脑血管生理功能。我们发现了在对瓦尔萨尔瓦动作和站立的脑血管反应方面存在性别差异。在瓦尔萨尔瓦动作的第二后期,男性有更大的脑血管收缩(或女性有更大的脑血管舒张),且站立时男性的脑血管阻力指数增加,而女性则无。此外,我们的研究结果表明,月经周期阶段和口服避孕药的使用均可影响静息和主动站立时的心血管功能。